Publications by authors named "A M Gero"
Article Synopsis
- The 2019 "Domestic Gag Rule" implemented by the Trump administration led to a significant reduction in services offered by the Title X family planning program, with many grantees withdrawing from it.
- A study analyzing data from 2018-2022 found a 16% national decline in services during the rule change period, with states losing more capacity experiencing even greater reductions in reproductive health services.
- The results indicated that service levels, including contraceptive methods and STI services, did not improve in the years following the repeal of the rule, showing a slow recovery for Title X services.
Article Synopsis
- The study explored contraceptive use and discontinuation rates between gender-expansive individuals and cis-women, using survey data from the HER Salt Lake Contraceptive Initiative.
- Out of 4,289 participants, 4% identified as gender-expansive, with the majority engaging in sexual activity with men and opting for long-term contraceptive methods like IUDs or Implants.
- The results showed no significant differences in contraceptive method selection or discontinuation rates between gender-expansive individuals and cis-women, suggesting healthcare providers should feel confident discussing contraceptive options with all patients.
Background: Same-day start removes barriers to contraceptive initiation and may reduce the risk of unintended pregnancy. It may be appropriate for all contraceptive methods, but we lack data comparing methods.
Objective: This study aimed to assess the frequency of same-day start with 6 contraceptive methods among new contraceptive users and describe the efficacy of same-day start in terms of first-cycle pregnancy risk overall and by each method.
Objectives: In an established cohort of HER Salt Lake Contraceptive Initiative participants with a prior intrauterine device (IUD) placement, we sought to (1) define the proportion of participants who reported a negative Patient Acceptable Symptom State (PASS) response, (2) explore factors associated with an unacceptable PASS response, and (3) identify pain management preferences for IUD placement.
Study Design: A retrospective survey was sent to 1440 HER Salt Lake IUD users. A PASS question queried IUD placement pain experience acceptability.
Objective: To estimate the incidence of ovulation suppression within five days of etonogestrel 68 mg implant insertion in the presence of a dominant follicle with and without same-day ulipristal acetate.
Study Design: This single site non-masked, exploratory randomized trial recruited people age 18-35 years with regular menstrual cycles, no pregnancy risk, and confirmed ovulatory function. We initiated transvaginal ultrasound examinations on menstrual day 7-9 and randomized participants 1:1 to etonogestrel implant alone or with concomitant ulipristal acetate 30 mg oral when a dominant follicle reached ≥14 mm in diameter.